Giulia Yuni Davanço

Giulia Yuni Davanço

Auto-generated profile, based on publicly available information

Giulia Yuni Davanço

Departamento de Ciências Farmacêuticas Centro Universitário FMABC Santo André SP Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2023 in ABC Heart Failure & Cardiomyopathy
Verified
Journal Article
Open access
PDF file
GDGiulia Yuni Davanço
Giulia Yuni Davanço
Matheus de Figueiredo TorresMatheus de Figueiredo Torres
Matheus de Figueiredo Torres
NMNeif Murad
Neif Murad
GVGlaucia Veiga
Glaucia Veiga
PRPedro Henrique Alves Reis
Pedro Henrique Alves Reis
FFFernando Luiz Affonso Fonseca
Fernando Luiz Affonso Fonseca
Background: The SARS-CoV-2 virus is responsible for the COVID-19 pandemic. Several adverse effects on the cardiovascular system were observed in patients hospitalized for COVID-19. SARS-CoV-2 infection added another possible arrhythmia-causing agent due to increased cytokines. It is believed that patients who have had COVID-19 are more prone to develop cardiovascular disease after infection. Heart rate variability (HRV) is an important marker of heart health, with lower values indicating a decrease in vagal heart rate control. Objectives: To analyze the [...] Abstract Background: The SARS-CoV-2 virus is responsible for the COVID-19 pandemic. Several adverse effects on the cardiovascular system were observed in patients hospitalized for COVID-19. SARS-CoV-2 infection added another possible arrhythmia-causing agent due to increased cytokines. It is believed that patients who have had COVID-19 are more prone to develop cardiovascular disease after infection. Heart rate variability (HRV) is an important marker of heart health, with lower values indicating a decrease in vagal heart rate control. Objectives: To analyze the